![Rachel King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rachel King
Director/Board Member at
NOVAVAX, INC.
Net worth: 483 448 $ as of 31/05/2026
Profile
Rachel K.
King was the founder of GlycoMimetics, Inc., founded in 2003, and served as Director from 2021 to 2025.
Current jobs include Independent Director at Novavax, Inc. since 2018, Director at MdBio, Inc., Director at University of Maryland Biopark, Director at Learning Undefeated, Inc., and Independent Director at Fulcrum Therapeutics, Inc. starting in 2024.
Former jobs include Chief Executive Officer at Genetic Therapy, Inc. from 1996 to 1998, President, Chief Executive Officer & Director at Biotechnology Innovation Organization from 2022 to 2024, Director at Warp Drive Bio, Inc., Executive Vice President at ALZA Corp., Senior Vice President at Novartis Corp.
from 1999 to 2001, Principal at Bain & Co., Inc., and Principal at NEA Management Co. LLC from 2009 to 2012.
Education includes undergraduate degree from Dartmouth College and MBAistration from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC. 0.03% | 23/04/2026 | 44,070 ( 0.03% ) | 483 448 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Rachel King active positions
| Companies | Position | Start |
|---|---|---|
| NOVAVAX, INC. | Director/Board Member | 01/11/2018 |
| FULCRUM THERAPEUTICS, INC. | Director/Board Member | 12/11/2024 |
MdBio, Inc.
 MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services Non-profit bioscience networking and business development organization | Director/Board Member | - |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
University of Maryland Biopark
 University of Maryland Biopark Miscellaneous Commercial ServicesCommercial Services Operates as bio-medical research centre | Director/Board Member | - |
Former positions of Rachel King
| Companies | Position | End |
|---|---|---|
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Founder | 21/02/2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Chief Executive Officer | 04/03/2024 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Chief Executive Officer | 01/12/1998 |
| ░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Rachel King
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services Non-profit bioscience networking and business development organization | Commercial Services |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Commercial Services |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
University of Maryland Biopark
University of Maryland Biopark Miscellaneous Commercial ServicesCommercial Services Operates as bio-medical research centre | Commercial Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
- Stock Market
- Insiders
- Rachel King
